nodes	percent_of_prediction	percent_of_DWPC	metapath
Sertraline—CYP2B6—Sorafenib—liver cancer	0.0961	0.183	CbGbCtD
Sertraline—CYP2C19—Sorafenib—liver cancer	0.061	0.117	CbGbCtD
Sertraline—CYP2B6—Doxorubicin—liver cancer	0.0583	0.111	CbGbCtD
Sertraline—CYP1A2—Sorafenib—liver cancer	0.0563	0.108	CbGbCtD
Sertraline—CYP2C9—Sorafenib—liver cancer	0.0507	0.0969	CbGbCtD
Sertraline—ABCB1—Sorafenib—liver cancer	0.0492	0.0941	CbGbCtD
Sertraline—CYP2D6—Sorafenib—liver cancer	0.0464	0.0886	CbGbCtD
Sertraline—ABCB1—Doxorubicin—liver cancer	0.0299	0.0571	CbGbCtD
Sertraline—CYP3A4—Sorafenib—liver cancer	0.0295	0.0564	CbGbCtD
Sertraline—CYP2D6—Doxorubicin—liver cancer	0.0282	0.0538	CbGbCtD
Sertraline—CYP3A4—Doxorubicin—liver cancer	0.0179	0.0342	CbGbCtD
Sertraline—Orthostatic hypotension—Epirubicin—liver cancer	0.000412	0.00135	CcSEcCtD
Sertraline—Affect lability—Doxorubicin—liver cancer	0.000411	0.00134	CcSEcCtD
Sertraline—Migraine—Doxorubicin—liver cancer	0.000411	0.00134	CcSEcCtD
Sertraline—Diarrhoea—Sorafenib—liver cancer	0.000411	0.00134	CcSEcCtD
Sertraline—Breast disorder—Epirubicin—liver cancer	0.000408	0.00133	CcSEcCtD
Sertraline—Toxic epidermal necrolysis—Epirubicin—liver cancer	0.000407	0.00133	CcSEcCtD
Sertraline—Face oedema—Doxorubicin—liver cancer	0.000403	0.00132	CcSEcCtD
Sertraline—Gastritis—Epirubicin—liver cancer	0.0004	0.00131	CcSEcCtD
Sertraline—Muscular weakness—Epirubicin—liver cancer	0.000398	0.0013	CcSEcCtD
Sertraline—Alanine aminotransferase increased—Epirubicin—liver cancer	0.000398	0.0013	CcSEcCtD
Sertraline—Dizziness—Sorafenib—liver cancer	0.000397	0.0013	CcSEcCtD
Sertraline—Mood swings—Doxorubicin—liver cancer	0.000396	0.00129	CcSEcCtD
Sertraline—Abdominal distension—Epirubicin—liver cancer	0.000393	0.00128	CcSEcCtD
Sertraline—Ataxia—Doxorubicin—liver cancer	0.000393	0.00128	CcSEcCtD
Sertraline—Dysphagia—Epirubicin—liver cancer	0.00039	0.00128	CcSEcCtD
Sertraline—Dehydration—Doxorubicin—liver cancer	0.000388	0.00127	CcSEcCtD
Sertraline—Dry skin—Doxorubicin—liver cancer	0.000383	0.00125	CcSEcCtD
Sertraline—Pancreatitis—Epirubicin—liver cancer	0.000383	0.00125	CcSEcCtD
Sertraline—Vomiting—Sorafenib—liver cancer	0.000382	0.00125	CcSEcCtD
Sertraline—Orthostatic hypotension—Doxorubicin—liver cancer	0.000382	0.00125	CcSEcCtD
Sertraline—Rash—Sorafenib—liver cancer	0.000379	0.00124	CcSEcCtD
Sertraline—Dermatitis—Sorafenib—liver cancer	0.000378	0.00124	CcSEcCtD
Sertraline—Breast disorder—Doxorubicin—liver cancer	0.000377	0.00123	CcSEcCtD
Sertraline—Toxic epidermal necrolysis—Doxorubicin—liver cancer	0.000376	0.00123	CcSEcCtD
Sertraline—Headache—Sorafenib—liver cancer	0.000376	0.00123	CcSEcCtD
Sertraline—Bronchitis—Epirubicin—liver cancer	0.000375	0.00123	CcSEcCtD
Sertraline—Pancytopenia—Epirubicin—liver cancer	0.000371	0.00121	CcSEcCtD
Sertraline—Gastritis—Doxorubicin—liver cancer	0.00037	0.00121	CcSEcCtD
Sertraline—Muscular weakness—Doxorubicin—liver cancer	0.000368	0.0012	CcSEcCtD
Sertraline—Alanine aminotransferase increased—Doxorubicin—liver cancer	0.000368	0.0012	CcSEcCtD
Sertraline—Dysuria—Epirubicin—liver cancer	0.000365	0.00119	CcSEcCtD
Sertraline—Abdominal distension—Doxorubicin—liver cancer	0.000363	0.00119	CcSEcCtD
Sertraline—Upper respiratory tract infection—Epirubicin—liver cancer	0.000363	0.00119	CcSEcCtD
Sertraline—Dysphagia—Doxorubicin—liver cancer	0.000361	0.00118	CcSEcCtD
Sertraline—Pollakiuria—Epirubicin—liver cancer	0.00036	0.00118	CcSEcCtD
Sertraline—Nausea—Sorafenib—liver cancer	0.000357	0.00117	CcSEcCtD
Sertraline—Photosensitivity reaction—Epirubicin—liver cancer	0.000356	0.00116	CcSEcCtD
Sertraline—Weight increased—Epirubicin—liver cancer	0.000355	0.00116	CcSEcCtD
Sertraline—Pancreatitis—Doxorubicin—liver cancer	0.000354	0.00116	CcSEcCtD
Sertraline—Weight decreased—Epirubicin—liver cancer	0.000353	0.00115	CcSEcCtD
Sertraline—Hyperglycaemia—Epirubicin—liver cancer	0.000352	0.00115	CcSEcCtD
Sertraline—Drowsiness—Epirubicin—liver cancer	0.000348	0.00114	CcSEcCtD
Sertraline—Bronchitis—Doxorubicin—liver cancer	0.000347	0.00114	CcSEcCtD
Sertraline—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.000345	0.00113	CcSEcCtD
Sertraline—Pancytopenia—Doxorubicin—liver cancer	0.000343	0.00112	CcSEcCtD
Sertraline—Neuropathy peripheral—Epirubicin—liver cancer	0.000341	0.00112	CcSEcCtD
Sertraline—Stomatitis—Epirubicin—liver cancer	0.000339	0.00111	CcSEcCtD
Sertraline—Jaundice—Epirubicin—liver cancer	0.000339	0.00111	CcSEcCtD
Sertraline—Conjunctivitis—Epirubicin—liver cancer	0.000338	0.00111	CcSEcCtD
Sertraline—Dysuria—Doxorubicin—liver cancer	0.000338	0.0011	CcSEcCtD
Sertraline—Upper respiratory tract infection—Doxorubicin—liver cancer	0.000336	0.0011	CcSEcCtD
Sertraline—Sweating—Epirubicin—liver cancer	0.000334	0.00109	CcSEcCtD
Sertraline—Pollakiuria—Doxorubicin—liver cancer	0.000334	0.00109	CcSEcCtD
Sertraline—Haematuria—Epirubicin—liver cancer	0.000332	0.00108	CcSEcCtD
Sertraline—Photosensitivity reaction—Doxorubicin—liver cancer	0.00033	0.00108	CcSEcCtD
Sertraline—Hepatobiliary disease—Epirubicin—liver cancer	0.000329	0.00108	CcSEcCtD
Sertraline—Weight increased—Doxorubicin—liver cancer	0.000329	0.00107	CcSEcCtD
Sertraline—Epistaxis—Epirubicin—liver cancer	0.000328	0.00107	CcSEcCtD
Sertraline—Weight decreased—Doxorubicin—liver cancer	0.000327	0.00107	CcSEcCtD
Sertraline—Sinusitis—Epirubicin—liver cancer	0.000326	0.00107	CcSEcCtD
Sertraline—Hyperglycaemia—Doxorubicin—liver cancer	0.000326	0.00106	CcSEcCtD
Sertraline—Agranulocytosis—Epirubicin—liver cancer	0.000325	0.00106	CcSEcCtD
Sertraline—Drowsiness—Doxorubicin—liver cancer	0.000322	0.00105	CcSEcCtD
Sertraline—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.000319	0.00104	CcSEcCtD
Sertraline—Bradycardia—Epirubicin—liver cancer	0.000318	0.00104	CcSEcCtD
Sertraline—Neuropathy peripheral—Doxorubicin—liver cancer	0.000316	0.00103	CcSEcCtD
Sertraline—Haemoglobin—Epirubicin—liver cancer	0.000314	0.00103	CcSEcCtD
Sertraline—Stomatitis—Doxorubicin—liver cancer	0.000314	0.00103	CcSEcCtD
Sertraline—Jaundice—Doxorubicin—liver cancer	0.000314	0.00103	CcSEcCtD
Sertraline—Rhinitis—Epirubicin—liver cancer	0.000313	0.00102	CcSEcCtD
Sertraline—Conjunctivitis—Doxorubicin—liver cancer	0.000313	0.00102	CcSEcCtD
Sertraline—Haemorrhage—Epirubicin—liver cancer	0.000312	0.00102	CcSEcCtD
Sertraline—Hepatitis—Epirubicin—liver cancer	0.000312	0.00102	CcSEcCtD
Sertraline—Hypoaesthesia—Epirubicin—liver cancer	0.000311	0.00102	CcSEcCtD
Sertraline—Pharyngitis—Epirubicin—liver cancer	0.00031	0.00101	CcSEcCtD
Sertraline—Sweating—Doxorubicin—liver cancer	0.000309	0.00101	CcSEcCtD
Sertraline—Urinary tract disorder—Epirubicin—liver cancer	0.000308	0.00101	CcSEcCtD
Sertraline—Oedema peripheral—Epirubicin—liver cancer	0.000308	0.00101	CcSEcCtD
Sertraline—Haematuria—Doxorubicin—liver cancer	0.000307	0.001	CcSEcCtD
Sertraline—Connective tissue disorder—Epirubicin—liver cancer	0.000307	0.001	CcSEcCtD
Sertraline—Urethral disorder—Epirubicin—liver cancer	0.000306	0.001	CcSEcCtD
Sertraline—Hepatobiliary disease—Doxorubicin—liver cancer	0.000304	0.000995	CcSEcCtD
Sertraline—Epistaxis—Doxorubicin—liver cancer	0.000304	0.000993	CcSEcCtD
Sertraline—Sinusitis—Doxorubicin—liver cancer	0.000302	0.000987	CcSEcCtD
Sertraline—Visual impairment—Epirubicin—liver cancer	0.000301	0.000984	CcSEcCtD
Sertraline—Agranulocytosis—Doxorubicin—liver cancer	0.0003	0.000982	CcSEcCtD
Sertraline—Erythema multiforme—Epirubicin—liver cancer	0.000295	0.000966	CcSEcCtD
Sertraline—Bradycardia—Doxorubicin—liver cancer	0.000294	0.000962	CcSEcCtD
Sertraline—Eye disorder—Epirubicin—liver cancer	0.000292	0.000954	CcSEcCtD
Sertraline—Tinnitus—Epirubicin—liver cancer	0.000291	0.000952	CcSEcCtD
Sertraline—Haemoglobin—Doxorubicin—liver cancer	0.00029	0.00095	CcSEcCtD
Sertraline—Flushing—Epirubicin—liver cancer	0.00029	0.000948	CcSEcCtD
Sertraline—Cardiac disorder—Epirubicin—liver cancer	0.00029	0.000948	CcSEcCtD
Sertraline—Rhinitis—Doxorubicin—liver cancer	0.00029	0.000947	CcSEcCtD
Sertraline—Haemorrhage—Doxorubicin—liver cancer	0.000289	0.000945	CcSEcCtD
Sertraline—Hepatitis—Doxorubicin—liver cancer	0.000289	0.000945	CcSEcCtD
Sertraline—Hypoaesthesia—Doxorubicin—liver cancer	0.000288	0.00094	CcSEcCtD
Sertraline—Pharyngitis—Doxorubicin—liver cancer	0.000287	0.000938	CcSEcCtD
Sertraline—Urinary tract disorder—Doxorubicin—liver cancer	0.000285	0.000933	CcSEcCtD
Sertraline—Oedema peripheral—Doxorubicin—liver cancer	0.000285	0.000931	CcSEcCtD
Sertraline—Connective tissue disorder—Doxorubicin—liver cancer	0.000284	0.000929	CcSEcCtD
Sertraline—Angiopathy—Epirubicin—liver cancer	0.000283	0.000927	CcSEcCtD
Sertraline—Urethral disorder—Doxorubicin—liver cancer	0.000283	0.000926	CcSEcCtD
Sertraline—Immune system disorder—Epirubicin—liver cancer	0.000282	0.000922	CcSEcCtD
Sertraline—Mediastinal disorder—Epirubicin—liver cancer	0.000281	0.00092	CcSEcCtD
Sertraline—Chills—Epirubicin—liver cancer	0.00028	0.000916	CcSEcCtD
Sertraline—Arrhythmia—Epirubicin—liver cancer	0.000279	0.000912	CcSEcCtD
Sertraline—Visual impairment—Doxorubicin—liver cancer	0.000278	0.000911	CcSEcCtD
Sertraline—Alopecia—Epirubicin—liver cancer	0.000276	0.000902	CcSEcCtD
Sertraline—Mental disorder—Epirubicin—liver cancer	0.000274	0.000895	CcSEcCtD
Sertraline—Erythema multiforme—Doxorubicin—liver cancer	0.000273	0.000893	CcSEcCtD
Sertraline—Erythema—Epirubicin—liver cancer	0.000272	0.000889	CcSEcCtD
Sertraline—Malnutrition—Epirubicin—liver cancer	0.000272	0.000889	CcSEcCtD
Sertraline—Eye disorder—Doxorubicin—liver cancer	0.00027	0.000883	CcSEcCtD
Sertraline—Tinnitus—Doxorubicin—liver cancer	0.000269	0.000881	CcSEcCtD
Sertraline—Cardiac disorder—Doxorubicin—liver cancer	0.000268	0.000877	CcSEcCtD
Sertraline—Flushing—Doxorubicin—liver cancer	0.000268	0.000877	CcSEcCtD
Sertraline—Flatulence—Epirubicin—liver cancer	0.000268	0.000876	CcSEcCtD
Sertraline—Tension—Epirubicin—liver cancer	0.000267	0.000872	CcSEcCtD
Sertraline—Dysgeusia—Epirubicin—liver cancer	0.000266	0.000871	CcSEcCtD
Sertraline—Nervousness—Epirubicin—liver cancer	0.000264	0.000863	CcSEcCtD
Sertraline—Back pain—Epirubicin—liver cancer	0.000263	0.00086	CcSEcCtD
Sertraline—Angiopathy—Doxorubicin—liver cancer	0.000262	0.000857	CcSEcCtD
Sertraline—Muscle spasms—Epirubicin—liver cancer	0.000261	0.000855	CcSEcCtD
Sertraline—Immune system disorder—Doxorubicin—liver cancer	0.000261	0.000853	CcSEcCtD
Sertraline—Mediastinal disorder—Doxorubicin—liver cancer	0.00026	0.000852	CcSEcCtD
Sertraline—Chills—Doxorubicin—liver cancer	0.000259	0.000848	CcSEcCtD
Sertraline—Arrhythmia—Doxorubicin—liver cancer	0.000258	0.000844	CcSEcCtD
Sertraline—Alopecia—Doxorubicin—liver cancer	0.000255	0.000835	CcSEcCtD
Sertraline—Mental disorder—Doxorubicin—liver cancer	0.000253	0.000828	CcSEcCtD
Sertraline—Ill-defined disorder—Epirubicin—liver cancer	0.000252	0.000825	CcSEcCtD
Sertraline—Erythema—Doxorubicin—liver cancer	0.000252	0.000823	CcSEcCtD
Sertraline—Malnutrition—Doxorubicin—liver cancer	0.000252	0.000823	CcSEcCtD
Sertraline—Anaemia—Epirubicin—liver cancer	0.000251	0.000822	CcSEcCtD
Sertraline—Agitation—Epirubicin—liver cancer	0.00025	0.000817	CcSEcCtD
Sertraline—Flatulence—Doxorubicin—liver cancer	0.000248	0.000811	CcSEcCtD
Sertraline—Tension—Doxorubicin—liver cancer	0.000247	0.000807	CcSEcCtD
Sertraline—Dysgeusia—Doxorubicin—liver cancer	0.000246	0.000805	CcSEcCtD
Sertraline—Malaise—Epirubicin—liver cancer	0.000245	0.000802	CcSEcCtD
Sertraline—Nervousness—Doxorubicin—liver cancer	0.000244	0.000799	CcSEcCtD
Sertraline—Vertigo—Epirubicin—liver cancer	0.000244	0.000799	CcSEcCtD
Sertraline—Syncope—Epirubicin—liver cancer	0.000244	0.000797	CcSEcCtD
Sertraline—Leukopenia—Epirubicin—liver cancer	0.000243	0.000796	CcSEcCtD
Sertraline—Back pain—Doxorubicin—liver cancer	0.000243	0.000796	CcSEcCtD
Sertraline—Muscle spasms—Doxorubicin—liver cancer	0.000242	0.000791	CcSEcCtD
Sertraline—Palpitations—Epirubicin—liver cancer	0.00024	0.000786	CcSEcCtD
Sertraline—Loss of consciousness—Epirubicin—liver cancer	0.000239	0.000781	CcSEcCtD
Sertraline—Cough—Epirubicin—liver cancer	0.000237	0.000776	CcSEcCtD
Sertraline—Convulsion—Epirubicin—liver cancer	0.000236	0.00077	CcSEcCtD
Sertraline—Hypertension—Epirubicin—liver cancer	0.000235	0.000768	CcSEcCtD
Sertraline—Ill-defined disorder—Doxorubicin—liver cancer	0.000233	0.000763	CcSEcCtD
Sertraline—Anaemia—Doxorubicin—liver cancer	0.000233	0.00076	CcSEcCtD
Sertraline—Arthralgia—Epirubicin—liver cancer	0.000231	0.000757	CcSEcCtD
Sertraline—Myalgia—Epirubicin—liver cancer	0.000231	0.000757	CcSEcCtD
Sertraline—Chest pain—Epirubicin—liver cancer	0.000231	0.000757	CcSEcCtD
Sertraline—Agitation—Doxorubicin—liver cancer	0.000231	0.000756	CcSEcCtD
Sertraline—Anxiety—Epirubicin—liver cancer	0.000231	0.000754	CcSEcCtD
Sertraline—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.00023	0.000752	CcSEcCtD
Sertraline—Discomfort—Epirubicin—liver cancer	0.000229	0.000748	CcSEcCtD
Sertraline—Malaise—Doxorubicin—liver cancer	0.000227	0.000742	CcSEcCtD
Sertraline—Dry mouth—Epirubicin—liver cancer	0.000226	0.00074	CcSEcCtD
Sertraline—Vertigo—Doxorubicin—liver cancer	0.000226	0.000739	CcSEcCtD
Sertraline—Syncope—Doxorubicin—liver cancer	0.000226	0.000738	CcSEcCtD
Sertraline—Leukopenia—Doxorubicin—liver cancer	0.000225	0.000736	CcSEcCtD
Sertraline—Confusional state—Epirubicin—liver cancer	0.000224	0.000732	CcSEcCtD
Sertraline—Palpitations—Doxorubicin—liver cancer	0.000222	0.000727	CcSEcCtD
Sertraline—Oedema—Epirubicin—liver cancer	0.000222	0.000726	CcSEcCtD
Sertraline—Anaphylactic shock—Epirubicin—liver cancer	0.000222	0.000726	CcSEcCtD
Sertraline—Loss of consciousness—Doxorubicin—liver cancer	0.000221	0.000723	CcSEcCtD
Sertraline—Cough—Doxorubicin—liver cancer	0.00022	0.000718	CcSEcCtD
Sertraline—Shock—Epirubicin—liver cancer	0.000218	0.000714	CcSEcCtD
Sertraline—Convulsion—Doxorubicin—liver cancer	0.000218	0.000713	CcSEcCtD
Sertraline—Nervous system disorder—Epirubicin—liver cancer	0.000218	0.000711	CcSEcCtD
Sertraline—Thrombocytopenia—Epirubicin—liver cancer	0.000217	0.00071	CcSEcCtD
Sertraline—Hypertension—Doxorubicin—liver cancer	0.000217	0.00071	CcSEcCtD
Sertraline—Tachycardia—Epirubicin—liver cancer	0.000217	0.000708	CcSEcCtD
Sertraline—Skin disorder—Epirubicin—liver cancer	0.000216	0.000705	CcSEcCtD
Sertraline—Hyperhidrosis—Epirubicin—liver cancer	0.000215	0.000701	CcSEcCtD
Sertraline—Chest pain—Doxorubicin—liver cancer	0.000214	0.0007	CcSEcCtD
Sertraline—Myalgia—Doxorubicin—liver cancer	0.000214	0.0007	CcSEcCtD
Sertraline—Arthralgia—Doxorubicin—liver cancer	0.000214	0.0007	CcSEcCtD
Sertraline—Anxiety—Doxorubicin—liver cancer	0.000213	0.000698	CcSEcCtD
Sertraline—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000213	0.000695	CcSEcCtD
Sertraline—Discomfort—Doxorubicin—liver cancer	0.000212	0.000692	CcSEcCtD
Sertraline—Anorexia—Epirubicin—liver cancer	0.000212	0.000692	CcSEcCtD
Sertraline—Dry mouth—Doxorubicin—liver cancer	0.000209	0.000685	CcSEcCtD
Sertraline—Hypotension—Epirubicin—liver cancer	0.000207	0.000678	CcSEcCtD
Sertraline—Confusional state—Doxorubicin—liver cancer	0.000207	0.000677	CcSEcCtD
Sertraline—Oedema—Doxorubicin—liver cancer	0.000205	0.000671	CcSEcCtD
Sertraline—Anaphylactic shock—Doxorubicin—liver cancer	0.000205	0.000671	CcSEcCtD
Sertraline—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000202	0.000661	CcSEcCtD
Sertraline—Shock—Doxorubicin—liver cancer	0.000202	0.00066	CcSEcCtD
Sertraline—Nervous system disorder—Doxorubicin—liver cancer	0.000201	0.000658	CcSEcCtD
Sertraline—Thrombocytopenia—Doxorubicin—liver cancer	0.000201	0.000657	CcSEcCtD
Sertraline—Insomnia—Epirubicin—liver cancer	0.000201	0.000656	CcSEcCtD
Sertraline—Tachycardia—Doxorubicin—liver cancer	0.0002	0.000655	CcSEcCtD
Sertraline—Skin disorder—Doxorubicin—liver cancer	0.000199	0.000652	CcSEcCtD
Sertraline—Paraesthesia—Epirubicin—liver cancer	0.000199	0.000651	CcSEcCtD
Sertraline—Hyperhidrosis—Doxorubicin—liver cancer	0.000198	0.000649	CcSEcCtD
Sertraline—Dyspnoea—Epirubicin—liver cancer	0.000198	0.000647	CcSEcCtD
Sertraline—Somnolence—Epirubicin—liver cancer	0.000197	0.000645	CcSEcCtD
Sertraline—Anorexia—Doxorubicin—liver cancer	0.000196	0.00064	CcSEcCtD
Sertraline—Dyspepsia—Epirubicin—liver cancer	0.000195	0.000639	CcSEcCtD
Sertraline—Decreased appetite—Epirubicin—liver cancer	0.000193	0.000631	CcSEcCtD
Sertraline—Hypotension—Doxorubicin—liver cancer	0.000192	0.000627	CcSEcCtD
Sertraline—Gastrointestinal disorder—Epirubicin—liver cancer	0.000192	0.000626	CcSEcCtD
Sertraline—Fatigue—Epirubicin—liver cancer	0.000191	0.000626	CcSEcCtD
Sertraline—Constipation—Epirubicin—liver cancer	0.00019	0.00062	CcSEcCtD
Sertraline—Pain—Epirubicin—liver cancer	0.00019	0.00062	CcSEcCtD
Sertraline—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000187	0.000612	CcSEcCtD
Sertraline—Insomnia—Doxorubicin—liver cancer	0.000186	0.000607	CcSEcCtD
Sertraline—Paraesthesia—Doxorubicin—liver cancer	0.000184	0.000603	CcSEcCtD
Sertraline—Dyspnoea—Doxorubicin—liver cancer	0.000183	0.000598	CcSEcCtD
Sertraline—Feeling abnormal—Epirubicin—liver cancer	0.000183	0.000598	CcSEcCtD
Sertraline—Somnolence—Doxorubicin—liver cancer	0.000183	0.000597	CcSEcCtD
Sertraline—Gastrointestinal pain—Epirubicin—liver cancer	0.000181	0.000593	CcSEcCtD
Sertraline—Dyspepsia—Doxorubicin—liver cancer	0.000181	0.000591	CcSEcCtD
Sertraline—Decreased appetite—Doxorubicin—liver cancer	0.000178	0.000584	CcSEcCtD
Sertraline—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000177	0.00058	CcSEcCtD
Sertraline—Fatigue—Doxorubicin—liver cancer	0.000177	0.000579	CcSEcCtD
Sertraline—Urticaria—Epirubicin—liver cancer	0.000176	0.000576	CcSEcCtD
Sertraline—Constipation—Doxorubicin—liver cancer	0.000176	0.000574	CcSEcCtD
Sertraline—Pain—Doxorubicin—liver cancer	0.000176	0.000574	CcSEcCtD
Sertraline—Body temperature increased—Epirubicin—liver cancer	0.000175	0.000574	CcSEcCtD
Sertraline—Abdominal pain—Epirubicin—liver cancer	0.000175	0.000574	CcSEcCtD
Sertraline—Feeling abnormal—Doxorubicin—liver cancer	0.000169	0.000553	CcSEcCtD
Sertraline—Gastrointestinal pain—Doxorubicin—liver cancer	0.000168	0.000549	CcSEcCtD
Sertraline—Hypersensitivity—Epirubicin—liver cancer	0.000163	0.000535	CcSEcCtD
Sertraline—Urticaria—Doxorubicin—liver cancer	0.000163	0.000533	CcSEcCtD
Sertraline—Abdominal pain—Doxorubicin—liver cancer	0.000162	0.000531	CcSEcCtD
Sertraline—Body temperature increased—Doxorubicin—liver cancer	0.000162	0.000531	CcSEcCtD
Sertraline—Asthenia—Epirubicin—liver cancer	0.000159	0.000521	CcSEcCtD
Sertraline—Pruritus—Epirubicin—liver cancer	0.000157	0.000513	CcSEcCtD
Sertraline—Diarrhoea—Epirubicin—liver cancer	0.000152	0.000496	CcSEcCtD
Sertraline—Hypersensitivity—Doxorubicin—liver cancer	0.000151	0.000495	CcSEcCtD
Sertraline—Asthenia—Doxorubicin—liver cancer	0.000147	0.000482	CcSEcCtD
Sertraline—Dizziness—Epirubicin—liver cancer	0.000147	0.00048	CcSEcCtD
Sertraline—Pruritus—Doxorubicin—liver cancer	0.000145	0.000475	CcSEcCtD
Sertraline—Vomiting—Epirubicin—liver cancer	0.000141	0.000461	CcSEcCtD
Sertraline—Diarrhoea—Doxorubicin—liver cancer	0.00014	0.000459	CcSEcCtD
Sertraline—Rash—Epirubicin—liver cancer	0.00014	0.000457	CcSEcCtD
Sertraline—Dermatitis—Epirubicin—liver cancer	0.00014	0.000457	CcSEcCtD
Sertraline—Headache—Epirubicin—liver cancer	0.000139	0.000455	CcSEcCtD
Sertraline—Dizziness—Doxorubicin—liver cancer	0.000136	0.000444	CcSEcCtD
Sertraline—Nausea—Epirubicin—liver cancer	0.000132	0.000431	CcSEcCtD
Sertraline—Vomiting—Doxorubicin—liver cancer	0.000131	0.000427	CcSEcCtD
Sertraline—Rash—Doxorubicin—liver cancer	0.000129	0.000423	CcSEcCtD
Sertraline—Dermatitis—Doxorubicin—liver cancer	0.000129	0.000423	CcSEcCtD
Sertraline—Headache—Doxorubicin—liver cancer	0.000129	0.000421	CcSEcCtD
Sertraline—Nausea—Doxorubicin—liver cancer	0.000122	0.000399	CcSEcCtD
Sertraline—CYP2C9—Metabolism—GLUL—liver cancer	3.21e-05	0.000188	CbGpPWpGaD
Sertraline—MAOA—Metabolism—HMOX1—liver cancer	3.18e-05	0.000186	CbGpPWpGaD
Sertraline—ABCB1—Transmembrane transport of small molecules—HMOX1—liver cancer	3.14e-05	0.000184	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—NR1H4—liver cancer	3.13e-05	0.000183	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—TAT—liver cancer	3.12e-05	0.000183	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—NR1H4—liver cancer	3.1e-05	0.000182	CbGpPWpGaD
Sertraline—MAOB—Metabolism—PIK3CD—liver cancer	3.08e-05	0.000181	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—GSTA3—liver cancer	3.07e-05	0.00018	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—GSTA4—liver cancer	3.06e-05	0.000179	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—GSTA3—liver cancer	3.05e-05	0.000179	CbGpPWpGaD
Sertraline—MAOB—Metabolism—ALB—liver cancer	3.04e-05	0.000178	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—liver cancer	3.01e-05	0.000176	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—HPGDS—liver cancer	3.01e-05	0.000176	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—liver cancer	3e-05	0.000176	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	2.99e-05	0.000175	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—GSTA4—liver cancer	2.98e-05	0.000175	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—GSTA2—liver cancer	2.98e-05	0.000175	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—liver cancer	2.97e-05	0.000174	CbGpPWpGaD
Sertraline—MAOA—Metabolism—GSTM1—liver cancer	2.96e-05	0.000174	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—GSTA2—liver cancer	2.91e-05	0.00017	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—GSTA1—liver cancer	2.87e-05	0.000168	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—NAT2—liver cancer	2.84e-05	0.000167	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—GSTA4—liver cancer	2.81e-05	0.000165	CbGpPWpGaD
Sertraline—MAOA—Metabolism—CYP1A1—liver cancer	2.81e-05	0.000165	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—GSTA1—liver cancer	2.8e-05	0.000164	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	2.8e-05	0.000164	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—GSTA4—liver cancer	2.79e-05	0.000163	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	2.78e-05	0.000163	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—NAT2—liver cancer	2.77e-05	0.000163	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—GLUL—liver cancer	2.75e-05	0.000161	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—CPT1B—liver cancer	2.75e-05	0.000161	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—GSTA2—liver cancer	2.74e-05	0.000161	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—liver cancer	2.73e-05	0.00016	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—ALDOB—liver cancer	2.72e-05	0.00016	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	2.72e-05	0.00016	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—GSTA2—liver cancer	2.72e-05	0.000159	CbGpPWpGaD
Sertraline—MAOB—Metabolism—PIK3CB—liver cancer	2.69e-05	0.000158	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—PSMD10—liver cancer	2.68e-05	0.000157	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—PSMA4—liver cancer	2.68e-05	0.000157	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—ALDOB—liver cancer	2.66e-05	0.000156	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—NR1H4—liver cancer	2.65e-05	0.000155	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—GSTA1—liver cancer	2.64e-05	0.000155	CbGpPWpGaD
Sertraline—MAOA—Metabolism—MTHFR—liver cancer	2.62e-05	0.000154	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—GSTA1—liver cancer	2.62e-05	0.000154	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—NAT2—liver cancer	2.61e-05	0.000153	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—GOT2—liver cancer	2.61e-05	0.000153	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—GSTA3—liver cancer	2.6e-05	0.000153	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—CRABP1—liver cancer	2.6e-05	0.000152	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—NAT2—liver cancer	2.59e-05	0.000152	CbGpPWpGaD
Sertraline—MAOA—Metabolism—PPARA—liver cancer	2.57e-05	0.000151	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	2.55e-05	0.00015	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—CRABP1—liver cancer	2.54e-05	0.000149	CbGpPWpGaD
Sertraline—ABCB1—Transmembrane transport of small molecules—PPARA—liver cancer	2.53e-05	0.000149	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—ALDOB—liver cancer	2.5e-05	0.000147	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—liver cancer	2.49e-05	0.000146	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—ALDOB—liver cancer	2.48e-05	0.000146	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	2.47e-05	0.000145	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—CYP2E1—liver cancer	2.45e-05	0.000144	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—CRABP1—liver cancer	2.39e-05	0.00014	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—GSTA4—liver cancer	2.38e-05	0.00014	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—CRABP1—liver cancer	2.37e-05	0.000139	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	2.34e-05	0.000137	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	2.33e-05	0.000136	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—GSTA2—liver cancer	2.32e-05	0.000136	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—CYCS—liver cancer	2.29e-05	0.000134	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—HPGDS—liver cancer	2.27e-05	0.000133	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—liver cancer	2.26e-05	0.000132	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—GGT1—liver cancer	2.25e-05	0.000132	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—GOT1—liver cancer	2.25e-05	0.000132	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—GSTA1—liver cancer	2.24e-05	0.000131	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—HPGDS—liver cancer	2.22e-05	0.00013	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—NAT2—liver cancer	2.21e-05	0.00013	CbGpPWpGaD
Sertraline—MAOA—Metabolism—PIK3CG—liver cancer	2.2e-05	0.000129	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	2.13e-05	0.000125	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—liver cancer	2.13e-05	0.000125	CbGpPWpGaD
Sertraline—MAOA—Metabolism—PPARG—liver cancer	2.12e-05	0.000125	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—ALDOB—liver cancer	2.12e-05	0.000124	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—CPT1B—liver cancer	2.12e-05	0.000124	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—GLUL—liver cancer	2.12e-05	0.000124	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—HPGDS—liver cancer	2.09e-05	0.000122	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	2.09e-05	0.000122	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—HPGDS—liver cancer	2.07e-05	0.000121	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—liver cancer	2.06e-05	0.000121	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	2.06e-05	0.000121	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—NR1H4—liver cancer	2.04e-05	0.00012	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism of lipids and lipoproteins—ALB—liver cancer	2.03e-05	0.000119	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—CRABP1—liver cancer	2.02e-05	0.000119	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—PSMD10—liver cancer	2.02e-05	0.000119	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—PSMA4—liver cancer	2.02e-05	0.000119	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—GSTP1—liver cancer	2.02e-05	0.000118	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—GSTA3—liver cancer	2.01e-05	0.000118	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—HMOX1—liver cancer	1.99e-05	0.000117	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—PSMD10—liver cancer	1.98e-05	0.000116	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—PSMA4—liver cancer	1.98e-05	0.000116	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—GOT2—liver cancer	1.97e-05	0.000115	CbGpPWpGaD
Sertraline—MAOA—Metabolism—PIK3CD—liver cancer	1.93e-05	0.000113	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—GOT2—liver cancer	1.92e-05	0.000113	CbGpPWpGaD
Sertraline—MAOA—Metabolism—ALB—liver cancer	1.91e-05	0.000112	CbGpPWpGaD
Sertraline—ABCB1—Transmembrane transport of small molecules—ALB—liver cancer	1.88e-05	0.00011	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.88e-05	0.00011	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—PSMD10—liver cancer	1.86e-05	0.000109	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—PSMA4—liver cancer	1.86e-05	0.000109	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—GSTM1—liver cancer	1.86e-05	0.000109	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—CYP2E1—liver cancer	1.85e-05	0.000109	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.85e-05	0.000109	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—PSMD10—liver cancer	1.85e-05	0.000108	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—PSMA4—liver cancer	1.85e-05	0.000108	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—GSTA4—liver cancer	1.84e-05	0.000108	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	1.82e-05	0.000107	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—GOT2—liver cancer	1.81e-05	0.000106	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—CYP2E1—liver cancer	1.81e-05	0.000106	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—GOT2—liver cancer	1.8e-05	0.000105	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.79e-05	0.000105	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—GSTA2—liver cancer	1.79e-05	0.000105	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—HPGDS—liver cancer	1.77e-05	0.000104	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—CYP1A1—liver cancer	1.76e-05	0.000103	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—liver cancer	1.76e-05	0.000103	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—CYCS—liver cancer	1.73e-05	0.000102	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—GSTA1—liver cancer	1.73e-05	0.000101	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—NAT2—liver cancer	1.71e-05	0.0001	CbGpPWpGaD
Sertraline—ABCB1—Transmembrane transport of small molecules—RAF1—liver cancer	1.7e-05	9.99e-05	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—CYP2E1—liver cancer	1.7e-05	9.98e-05	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—GOT1—liver cancer	1.7e-05	9.96e-05	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—GGT1—liver cancer	1.7e-05	9.96e-05	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—CYCS—liver cancer	1.69e-05	9.91e-05	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—CYP2E1—liver cancer	1.69e-05	9.89e-05	CbGpPWpGaD
Sertraline—MAOA—Metabolism—PIK3CB—liver cancer	1.69e-05	9.89e-05	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—GGT1—liver cancer	1.66e-05	9.72e-05	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—GOT1—liver cancer	1.66e-05	9.72e-05	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—MTHFR—liver cancer	1.64e-05	9.62e-05	CbGpPWpGaD
Sertraline—MAOB—Metabolism—PIK3CA—liver cancer	1.64e-05	9.6e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—ALDOB—liver cancer	1.64e-05	9.6e-05	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.63e-05	9.58e-05	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—PPARA—liver cancer	1.61e-05	9.44e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.6e-05	9.39e-05	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—CYCS—liver cancer	1.59e-05	9.34e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.58e-05	9.27e-05	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—CYCS—liver cancer	1.58e-05	9.26e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—PSMA4—liver cancer	1.58e-05	9.25e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—PSMD10—liver cancer	1.58e-05	9.25e-05	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—GGT1—liver cancer	1.56e-05	9.16e-05	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—GOT1—liver cancer	1.56e-05	9.16e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—CRABP1—liver cancer	1.56e-05	9.16e-05	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—GGT1—liver cancer	1.55e-05	9.08e-05	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—GOT1—liver cancer	1.55e-05	9.08e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—GOT2—liver cancer	1.53e-05	8.99e-05	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—GSTP1—liver cancer	1.53e-05	8.95e-05	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—HMOX1—liver cancer	1.51e-05	8.83e-05	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—GSTP1—liver cancer	1.49e-05	8.74e-05	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—HMOX1—liver cancer	1.47e-05	8.61e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—CYP2E1—liver cancer	1.44e-05	8.46e-05	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—GSTP1—liver cancer	1.4e-05	8.23e-05	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—GSTM1—liver cancer	1.4e-05	8.22e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.4e-05	8.19e-05	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—GSTP1—liver cancer	1.39e-05	8.16e-05	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—HMOX1—liver cancer	1.38e-05	8.12e-05	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—PIK3CG—liver cancer	1.38e-05	8.08e-05	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—HMOX1—liver cancer	1.37e-05	8.05e-05	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—GSTM1—liver cancer	1.37e-05	8.03e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—HPGDS—liver cancer	1.37e-05	8.01e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—CYCS—liver cancer	1.35e-05	7.91e-05	CbGpPWpGaD
Sertraline—MAOB—Metabolism—AKT1—liver cancer	1.34e-05	7.85e-05	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—PPARG—liver cancer	1.33e-05	7.8e-05	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—CYP1A1—liver cancer	1.33e-05	7.8e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—GGT1—liver cancer	1.32e-05	7.76e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—GOT1—liver cancer	1.32e-05	7.76e-05	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—CYP1A1—liver cancer	1.3e-05	7.61e-05	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—GSTM1—liver cancer	1.29e-05	7.56e-05	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—GSTM1—liver cancer	1.28e-05	7.5e-05	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—MTHFR—liver cancer	1.24e-05	7.27e-05	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—CYP1A1—liver cancer	1.22e-05	7.17e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—PSMA4—liver cancer	1.22e-05	7.13e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—PSMD10—liver cancer	1.22e-05	7.13e-05	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—PPARA—liver cancer	1.22e-05	7.13e-05	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—CYP1A1—liver cancer	1.21e-05	7.11e-05	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—PIK3CD—liver cancer	1.21e-05	7.1e-05	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—MTHFR—liver cancer	1.21e-05	7.09e-05	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—ALB—liver cancer	1.2e-05	7.01e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—GSTP1—liver cancer	1.19e-05	6.97e-05	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—PPARA—liver cancer	1.19e-05	6.96e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—GOT2—liver cancer	1.18e-05	6.94e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—HMOX1—liver cancer	1.17e-05	6.88e-05	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—MTHFR—liver cancer	1.14e-05	6.69e-05	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—MTHFR—liver cancer	1.13e-05	6.63e-05	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—PPARA—liver cancer	1.12e-05	6.56e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—CYP2E1—liver cancer	1.11e-05	6.53e-05	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—PPARA—liver cancer	1.11e-05	6.5e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—GSTM1—liver cancer	1.09e-05	6.41e-05	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.09e-05	6.41e-05	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—PIK3CB—liver cancer	1.06e-05	6.19e-05	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—PIK3CG—liver cancer	1.04e-05	6.11e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—CYCS—liver cancer	1.04e-05	6.11e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—CYP1A1—liver cancer	1.04e-05	6.07e-05	CbGpPWpGaD
Sertraline—MAOA—Metabolism—PIK3CA—liver cancer	1.03e-05	6.03e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—GGT1—liver cancer	1.02e-05	5.99e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—GOT1—liver cancer	1.02e-05	5.99e-05	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—PIK3CG—liver cancer	1.02e-05	5.96e-05	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—PPARG—liver cancer	1.01e-05	5.89e-05	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	9.96e-06	5.84e-05	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—PPARG—liver cancer	9.81e-06	5.75e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—MTHFR—liver cancer	9.66e-06	5.66e-05	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—PIK3CG—liver cancer	9.58e-06	5.62e-05	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—PIK3CG—liver cancer	9.5e-06	5.57e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—PPARA—liver cancer	9.48e-06	5.56e-05	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—PPARG—liver cancer	9.25e-06	5.42e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—GSTP1—liver cancer	9.18e-06	5.38e-05	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—PPARG—liver cancer	9.17e-06	5.37e-05	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—PIK3CD—liver cancer	9.16e-06	5.37e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—HMOX1—liver cancer	9.05e-06	5.31e-05	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—ALB—liver cancer	9.04e-06	5.3e-05	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—PIK3CD—liver cancer	8.94e-06	5.24e-05	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—ALB—liver cancer	8.82e-06	5.17e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	8.51e-06	4.99e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—GSTM1—liver cancer	8.44e-06	4.95e-05	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—PIK3CD—liver cancer	8.42e-06	4.94e-05	CbGpPWpGaD
Sertraline—MAOA—Metabolism—AKT1—liver cancer	8.4e-06	4.92e-05	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—PIK3CD—liver cancer	8.35e-06	4.9e-05	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—ALB—liver cancer	8.32e-06	4.87e-05	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—ALB—liver cancer	8.24e-06	4.83e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—PIK3CG—liver cancer	8.12e-06	4.76e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—CYP1A1—liver cancer	8e-06	4.69e-05	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—PIK3CB—liver cancer	7.98e-06	4.68e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—PPARG—liver cancer	7.83e-06	4.59e-05	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—PIK3CB—liver cancer	7.79e-06	4.57e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—MTHFR—liver cancer	7.46e-06	4.37e-05	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—PIK3CB—liver cancer	7.34e-06	4.3e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—PPARA—liver cancer	7.32e-06	4.29e-05	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—PIK3CB—liver cancer	7.28e-06	4.27e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—PIK3CD—liver cancer	7.14e-06	4.18e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—ALB—liver cancer	7.04e-06	4.13e-05	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—PIK3CA—liver cancer	6.44e-06	3.77e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—PIK3CG—liver cancer	6.26e-06	3.67e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—PIK3CB—liver cancer	6.22e-06	3.65e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—PPARG—liver cancer	6.05e-06	3.54e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—PIK3CD—liver cancer	5.51e-06	3.23e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—ALB—liver cancer	5.44e-06	3.19e-05	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—AKT1—liver cancer	5.26e-06	3.08e-05	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—PIK3CA—liver cancer	4.87e-06	2.85e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—PIK3CB—liver cancer	4.8e-06	2.81e-05	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—PIK3CA—liver cancer	4.75e-06	2.78e-05	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—PIK3CA—liver cancer	4.48e-06	2.62e-05	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—PIK3CA—liver cancer	4.44e-06	2.6e-05	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—AKT1—liver cancer	3.98e-06	2.33e-05	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—AKT1—liver cancer	3.88e-06	2.27e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—PIK3CA—liver cancer	3.79e-06	2.22e-05	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—AKT1—liver cancer	3.66e-06	2.14e-05	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—AKT1—liver cancer	3.62e-06	2.12e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—AKT1—liver cancer	3.1e-06	1.82e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—PIK3CA—liver cancer	2.93e-06	1.72e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—AKT1—liver cancer	2.39e-06	1.4e-05	CbGpPWpGaD
